Sarepta Therapeutics, Inc. (SRPT) stock analysis

SRPT · Sarepta Therapeutics, Inc.

Latest recorded price: USD 15.13

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 33.1%, free cash flow margin -14.0%, ROIC -49.4%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare